One of the stronger cat survival evidence areas, limited to veterinarian-diagnosed CKD and specific therapeutic nutrition.
The atlas separates a biological hypothesis, a canine or feline measurement, a controlled clinical result and a commercial longevity claim. They are not interchangeable.
What was actually measured?
Uremic Episodes And Mortality
double-masked randomized controlled clinical trialA double-masked randomized controlled trial compared a renal diet with adult maintenance food in cats with stage 2 or 3 CKD.
cats with spontaneous stable stage 2 or 3 CKD · the renal diet reduced uremic events and mortality in the published trial
LimitationApplies to diagnosed CKD and the studied therapeutic-diet strategy, not healthy-cat longevity.
Ckd Progression And Survival
retrospective observational comparative-effectiveness studyA 2026 retrospective study associated renal-diet treatment in early CKD with slower progression and longer restricted mean survival over three years.
1,430 cats with early CKD in commercial clinical records · 31.0 versus 26.0 months restricted mean survival was reported
LimitationObservational treatment assignment, commercial database and diagnosed CKD population.
No human-to-pet conversion.
No diet selection or feeding amount is provided. CKD diagnosis, IRIS context, calorie needs, appetite and concurrent treatment require veterinary management.
“Pet supplement” is not a universal legal category.
FDA does not recognise a separate dietary-supplement category for animal products; depending on intended use, products are regulated as animal food or animal drugs. Disease-treatment or prevention claims can indicate new-animal-drug intent.
Open FDA source →Trace every material statement.
Page data version: 2026-08-18. Medical review is not claimed without a named sign-off.